D-1040-2017 Class II Terminated

Recalled by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical — Los Angeles, CA

Recall Details

Product Type
Drugs
Report Date
August 9, 2017
Initiation Date
July 12, 2017
Termination Date
January 14, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
120 vials

Product Description

Testosterone Cypionate + Progesterone, 200 mg/ 2.5 mg/mL ,10 mL amber glass vials, Rx Only, Compounded by AXIA Pharmaceutical, Los Angeles, CA 90025

Reason for Recall

CGMP Deviations

Distribution Pattern

There were only one customer in California

Code Information

Lot # 03022017+44906; BUD 08/29/17